Evommune (EVMN) 10% Holder LSP 7 Receives Award of 358,680 Shares

What Happened LSP 7 Cooperatief UA, which holds a reported 10% stake in Evommune (EVMN), received an award of 358,680 shares of common stock on February 17, 2026. The shares were recorded at $27.88 per share, for a total reported value of $9,999,998. The transaction is coded as an award/grant (A) — an acquisition rather than an open-market purchase.

Key Details

• Transaction date: 2026-02-17; Form 4 filed: 2026-02-19.
• Shares acquired: 358,680 at $27.88 per share; total value $9,999,998.
• Shares owned after transaction: not specified in the filing.
• Footnote: Securities are held of record by LSP 7 Cooperatief UA. LSP 7 Management B.V. is the sole director; its managing directors are Martijn Kleijwegt, Rene Kuijten and Joachim Rothe, who may be deemed to share beneficial ownership but each disclaims beneficial ownership.
• Filing timeliness: filing date is two days after the transaction date (within the typical 2-business-day Form 4 window).

Context This was an institutional award to a 10% record holder rather than an executive buy or sale. Awards/grants can reflect financing arrangements, compensation, or contractual issuances and do not by themselves signal insider trading intent. The footnote indicates an institutional holding structure and names managers who may be deemed to share beneficial ownership but disclaim it.